<DOC>
	<DOCNO>NCT02796560</DOCNO>
	<brief_summary>The purpose study compare efficacy tolerance generic travoprost brand name formulation . In open label , randomize , crossover study , primary outcome intraocular pressure secondary outcome tolerance drop , measure subjective questionnaire . Patients randomize receive either brand name generic travoprost first visit . At second visit 3 week later , intraocular pressure measure questionnaire complete tolerance medication . Patients receive formulation travoprost . At third final visit , another 3 week later , intraocular pressure measure questionnaire complete tolerance second medication .</brief_summary>
	<brief_title>Generic Travoprost Versus Brand Name Travoprost Patients With Primary Open Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Be apt give consent Have diagnostic primary open angle glaucoma ocular hypertension require treatment Angle closure glaucoma benefit peripheral iridotomy Known allergies travoprost one ingredient Current usage glaucoma drop travoprost Current usage topical corticosteroid Pregnancy Breast feed Monophthalmic Having benefit glaucoma surgery include trabeculectomies , implant drainage device , selective laser trabeculectomies Active intraocular inflammation Ocular surface disease interfere accurate measure intraocular pressure Any clinically significant ocular disease could interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Drugs , Generic</keyword>
	<keyword>Generic Equivalency</keyword>
</DOC>